Skip to main content
Log in

TGA releases 2019 data from its pharmacovigilance programme (PVIP)

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. TGA = Therapeutic Goods Administration; PVIP = Pharmacovigilance Inspection Programme

  2. Ten inspections were conducted in the first reporting period (between 1 September 2017 and 31 December 2018). Medicine sponsors inspected during the current 2019 period included large and small innovator companies, as well as sponsors of generic medicines, vaccines, OTC and complementary medicines.

  3. CAPA = Corrective and Preventative Actions

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

TGA releases 2019 data from its pharmacovigilance programme (PVIP). Reactions Weekly 1804, 7 (2020). https://doi.org/10.1007/s40278-020-78436-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-78436-3

Navigation